异动解读 | Applied Therapeutics Inc.(APLT)盘前大跌5.14%,因收到FDA关于遗传病药物研发警告信

异动解读
03 Dec 2024

应用治疗学公司APLT今日盘前大跌5.14%,引发市场关注。

导致股价大跌的主要原因是,该公司周一表示收到了美国食品及药物管理局(FDA)的一封警告信,该信针对其一项治疗遗传性酪氨酸血症(HT-1)药物的临床研究。

根据新闻报道,上周FDA拒绝批准其上述治疗药物,而本周初又收到警告信,这令投资者担心该公司未来药物研发和商业化前景受到影响,导致了今日大跌。公司正探索如何应对并修正研究进程中的问题。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10